Search

Showing "11154" results for ""

Resistant HIV strains persist after at least five years on suppressive HAART

Fosamprenavir recommended for approval as Telzir in Europe

New HIV clinical training resource available from Impact/Family Health International

AIDSpan Guide to applying to the Global Fund

Hormonal contraceptive associated with increased risk of HIV infection

Saquinavir levels higher in women, linked to better outcomes

French study shows HAART no benefit against HPV or pre-cancerous anal lesions

Offer and recommend HIV tests to all adults with TB, says UK public health doctor

New HCV guidelines recommend against routine screening in US

HIV infection changes the genes that affect development of tuberculosis

ARV-based HIV microbicides advanced by ground-breaking partnership

Rectal HIV microbicides still a distant prospect

Multicentre UK HIV cohort involving over 13,000 patients established

HIV-specific immune responses key to speed of disease progression

Microbicides pose new challenges for design of research studies

Microbicides 2004 marks new wave of HIV prevention trials

NRTIs inhibit mitochondrial protein activity in fat cells

New-Fill recommended for approval in US as Sculptra (amended)

Receive the latest HIV research and conference news

Showing "11154" results for ""

Resistant HIV strains persist after at least five years on suppressive HAART

Fosamprenavir recommended for approval as Telzir in Europe

New HIV clinical training resource available from Impact/Family Health International

AIDSpan Guide to applying to the Global Fund

Hormonal contraceptive associated with increased risk of HIV infection

Saquinavir levels higher in women, linked to better outcomes

French study shows HAART no benefit against HPV or pre-cancerous anal lesions

Offer and recommend HIV tests to all adults with TB, says UK public health doctor

New HCV guidelines recommend against routine screening in US

HIV infection changes the genes that affect development of tuberculosis

ARV-based HIV microbicides advanced by ground-breaking partnership

Rectal HIV microbicides still a distant prospect

Multicentre UK HIV cohort involving over 13,000 patients established

HIV-specific immune responses key to speed of disease progression

Microbicides pose new challenges for design of research studies

Microbicides 2004 marks new wave of HIV prevention trials

NRTIs inhibit mitochondrial protein activity in fat cells

New-Fill recommended for approval in US as Sculptra (amended)

Receive the latest HIV research and conference news